Objective:To study the roles of estradiol and various progestins on the regulation of coronary flow in female rabbits.
Methods:Ovariectomized adult female rabbits were treated with estradiol, with progesterone (or one of the following synthetic progestins: megace, norethindrone, or medroxyprogesterone acetate), or with both an estradiol and a progestin. Hearts were isolated and perfused at constant pressure by a modified Langendorff technique. Changes in coronary flow were determined at baseline and in response to direct infusion into the coronary circulation of NG-nitro-L-arginine (L-NNA), an inhibitor of nitric oxide (NO) synthase.
Results:Coronary flow rates were 40-50% greater in hearts of animals treated with estradiol than in control hearts of animals not treated with the hormone. Treatment of the animals with progestin alone had little effect on coronary flow. However, when administered with estradiol, it abrogated the estradiol-related increase in coronary flow. The increments in coronary flow evoked by estradiol were virtually abolished by L-NNA, an inhibitor of NO synthase. In hearts of animals treated with estradiol plus progesterone, L-NNA had no additional inhibitory effect on coronary flow to that of progesterone.
Conclusion:Estradiol decreases coronary vascular resistance (CVR) and hence increases coronary flow. Progestins attenuate this effect of estradiol.
1. Gorodeski GI. Impact of the menopause on the epidemiology and risk factors of coronary artery heart disease in women. Exp Gerontol1994;29:357-376.
2.
2. Gorodeski GI, Yang T, Levy MN, Goldfarb J, Utian WH. Effects of estrogen in vivo on coronary vascular resistance in perfused rabbit hearts. Am J Physiol1995;269:R1333-R1338.
3.
3. Elderman IS. Mechanism of action of steroid hormones. J Steroid Biochem Mol Biol1975;6:145-159.
4.
4. McGill HC, Sheridan PJ. Nuclear uptake of sex steroid hormones in the cardiovascular system of the baboon. Circ Res1981;48:238-244.
5.
5. Horwitz KB, Horwitz LD. Canine vascular tissues are targets for androgens, estrogens, progestins and glucocorticoids. J Clin Invest1982;69:750-758.
6.
6. Sheridan PJ, McGill HC, Jr. The nuclear uptake and retention of a synthetic progestin in the cardiovascular system of the baboon. Endocrinology1984;114:2015-2019.
7.
7. Ingegno MD, Money SR, Thelmo W, et al. Progesterone receptors in the human heart and great vessels. Lab Invest1988;59:353-356.
8.
8. Stumpf WE. Steroid hormones and the cardiovascular system: Direct action of estradiol, progesterone, testosterone, gluco and mineralocorticoids and soltriol (Vitamin D) on central nervous regulatory and peripheral tissues. Experientia1990;46:13-25.
9.
9. White MM, Zamudio S, Stevens T, et al. Estrogen, progesterone, and vascular reactivity: Potential cellular mechanisms. Endocr Rev1995;16:739-751.
10.
10. Sarrel PM, Lindsay D, Rosano DMC, Poole-Wilson PA. Angina and normal coronary arteries in women: Gynecologic findings. Am J Obstet Gynecol1992;167:467-472.
11.
11. Sarrel PM. How progestins compromise the cardiovascular effects of estrogens. Menopause1995;2:187-190.
12.
12. Adams MR, Register TC, Golden DL, Wagner JD, Williams JK. Medroxyprogesterone acetate antagonizes inhibitory effects of conjugated equine estrogens on coronary artery atherosclerosis. Arterioscler, Thromb, Vasc Biol1997;17:217-221.
13.
13. Miyagawa K, Rosch J, Stanczyk F, Hermsmeyer K. Medroxyprogesterone interferes with ovarian steroid protection against coronary vasospasm. Nat Med1997;3:324-327.
14.
14. Vedernikov YP, Liao QP, Jain V, Saade GR, Chwalisz K, Garfield RE. Effect of chronic treatment with 17β-estradiol and progesterone on endothelium-dependent and endothelium-independent relaxation in isolated aortic rings from ovariectomized rats. Am J Obstet Gynecol1997;176:603-608.
15.
15. Ueeda M, Silvia SK, Olsson RA. Nitric oxide modulates coronary autoregulation in the guinea pig. Circ Res1992;70:1296-1303.
16.
16. Rubboli A, Sobotka PA, Euler DE. Effect of acute edema on left ventricular function and coronary vascular resistance in the isolated rat heart. Am J Physiol1994;267:H1054-H1061.
17.
17. Buxton ILO, Check DJ, Eckman D, Westfall DP, Sanders KM, Keef KD. NG-nitro-L-arginine methyl ester and other alkyl esters of arginine are muscarinic receptor antagonists. Circ Res1993;72:387-395.
18.
18. Hilliard J, Eaton JW. Estradiol-17β, progesterone and 20α-hydroxypregn-4-en-3-one in rabbit ovarian venous plasma. II. From mating through implantation. Endocrinology1971;89:522-527.
19.
19. Batra S, Kallstrand K. Are there cyclic variations in estradiol secretion in the non-pregnant rabbit?Experientia1979;35:699-701.
20.
20. Richardson, LL. Steroid concentrations in rabbit oviducal fluid during oestrus and pseudopregnancy. J Reprod Fertil1981;62:427-431.
22. Graham JD, Clarke CL. Physiological action of progesterone in target tissues. Endocr Rev1997;18:502-519.
23.
23. Greiss FC, Anderson SG. Effect of ovarian hormones on the uterine vascular bed. Am J Obstet Gynecol1970;107:829-836.
24.
24. Gorodeski GI, Sheean LA, Utian WH. Sex hormone modulation of flow velocity in the parametrial artery of the pregnant rat. Am J Physiol1995;268:R614-R624.
25.
25. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J1992;6:3051-3064.
26.
26. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med1993;329:2002-2012.
27.
27. Williams JK, Adams MR, Klopfenstein HS. Estrogen modulates responses of atherosclerotic coronary arteries. Circulation1990;81:1680-1687.
28.
28. Williams JK, Adams MR, Herrington DM, Clarkson TB. Short-term administration of estrogen and vascular responses of atherosclerotic coronary arteries. J Am Coll Cardiol1992;20:452-457.
29.
29. Reis SE, Gloth ST, Blumenthal RS. Ethinyl estradiol acutely attenuates abnormal coronary vasomotor responses to acetylcholine in postmenopausal women. Circulation1994;89:52-60.
30.
30. The Writing Group for the Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. Effects of replacement therapy on endometrial histology in postmenopausal women. JAMA1996;275:370-375.
